4//SEC Filing
Daniels Karen K. 4
Accession 0001593968-19-000836
CIK 0000887247other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 6:00 PM ET
Size
5.1 KB
Accession
0001593968-19-000836
Insider Transaction Report
Form 4
Daniels Karen K.
Vice President of Operations
Transactions
- Sale
Common Stock
2019-03-20$2.30/sh−13,911$32,011→ 179,944 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.33, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001530197
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 6:00 PM ET
- Size
- 5.1 KB